Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Leukemia|February 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, et al.
Inflammatory Bowel Diseases|December 23, 2017
Clinoptilolite in Dextran Sulphate Sodium-Induced Murine Colitis: Efficacy and Safety of a Microparticulate PreparationStéphane Nizet, Eduardo Muñoz, Bernd L Fiebich, et al.
The American Journal of Surgical Pathology|May 16, 2020
Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 CasesIva Brčić, Feisal Yamani, Carrie Y Inwards, et al.
Plos One|October 28, 2014
Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strainsVikash Pandey, Marc Sultan, Karl Kashofer, et al.
Cancers|July 7, 2019
In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing RadiotherapyShukun Chen, Gerlinde Tauber, Tanja Langsenlehner, et al.
Wiener Klinische Wochenschrift|November 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care centerSonja Wurm, Michael Waltersdorfer, Simone Loindl, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
Frontiers in Physiology|September 13, 2012
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS CellsJustyna Jozefczuk, Karl Kashofer, Ramesh Ummanni, et al.
Scientific Data|December 10, 2015
Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypesWasco Wruck, Karl Kashofer, Samrina Rehman, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Pageof 12